Bioventus Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Bioventus Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2020 to Q1 2024.
  • Bioventus Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 30, 2024 was -$4.24M, a 115% decline year-over-year.
  • Bioventus Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$26.7M, a 143% decline from 2022.
  • Bioventus Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $62.1M, a 77.3% decline from 2021.
  • Bioventus Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $273M.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$4.24M -$31.6M -115% Jan 1, 2024 Mar 30, 2024 10-Q 2024-05-07
Q1 2023 $27.4M +$18.2M +197% Jan 1, 2023 Apr 1, 2023 10-Q 2024-05-07
Q1 2022 $9.21M -$98.3M -91.4% Jan 1, 2022 Apr 2, 2022 10-Q 2023-05-16
Q1 2021 $108M +$58.7M +120% Jan 1, 2021 Apr 3, 2021 10-Q 2022-05-11
Q1 2020 $48.8M Jan 1, 2020 Mar 28, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.